Does infliximab favourably affect growth in paediatric Crohn's disease?

被引：0
|
作者：
Hill, R. J. [1 ]
Lewindon, P. J. [1 ]
Ee, L. C.
Withers, G. D.
Connor, F. L.
Grange, I. [1 ]
Cleghorn, G. J. [1 ]
Davies, P. S. W. [1 ]
机构：
[1] Univ Queensland, Childrens Nutr Res Ctr, Brisbane, Qld 4072, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [31] Effect of infliximab on growth hormone secretion in adult Crohn's disease
    Armuzzi, A
    Bianchi, A
    De Pascalis, B
    Vincenti, F
    Mentella, MC
    Leo, D
    Fedeli, P
    Lupascu, A
    De Marinis, L
    Gasbarrini, A
    GASTROENTEROLOGY, 2005, 128 (04) : A496 - A496
  • [32] Infliximab and the bone in Crohn's disease
    Kunisaki, R
    Chaki, O
    Taguchi, T
    Sugiyama, T
    Sugita, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) : 789 - 790
  • [33] Halting infliximab in Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 793 - 793
  • [34] Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
    Kasparek, Michael S.
    Bruckmeier, Andreas
    Beigel, Florian
    Mueller, Mario H.
    Brand, Stephan
    Mansmann, Ulrich
    Jauch, Karl-Walter
    Ochsenkuehn, Thomas
    Kreis, Martin E.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (07) : 1207 - 1213
  • [35] Treatment of Crohn's disease with infliximab does not reduce hospital attendance or admission
    Arnott, IDR
    Ghosh, S
    GUT, 2002, 50 : A47 - A47
  • [36] A Crohn's Disease Patient Who Does Not Respond to Infliximab: What Is Next?
    Maharshak, Nitsan
    Plevy, Scott E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) : 1033 - 1038
  • [37] Infliximab does not increase postoperative complication rates in patients with Crohn's disease
    Marchal, L
    D'Haens, G
    Van Assche, G
    Hiele, M
    D'Hoore, A
    Penninckx, F
    Rutgeerts, P
    GASTROENTEROLOGY, 2003, 124 (04) : A207 - A207
  • [38] Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy
    Wang, Yizhong
    Gao, Xuefeng
    Ghozlane, Amine
    Hu, Hui
    Li, Xiaolu
    Xiao, Yongmei
    Li, Dan
    Yu, Guangjun
    Zhang, Ting
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (03): : 337 - 346
  • [39] The switch to biosimilar infliximab as a cause of treatment cessation in 3 paediatric patients with Crohn's disease
    Vande Velde, S.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (04) : 657 - 659
  • [40] Outcome of treat to target strategy in paediatric patients with Crohn's disease and ulcerative colitis on infliximab
    Yerlioglu, D.
    Cococcioni, L.
    ElZein, A.
    Sider, S.
    Chadokufa, S.
    Buckingham, R.
    Shah, N.
    Ocholi, A.
    Borrelli, O.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S305 - S305
12345